Pimecrolimus goes pharmacogenetic

June 1, 2002

Previewing what may become routine in a few years, researchers have used genetic profiling to evaluate efficacy and adverse effects of a drug undergoing clinical trials for the treatment of psoriasis.

Related Content:

Pediatric Dermatology | News